Eldridge JH, Egan MA, Matassov D, Hamm S, et al. A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses. Vaccine 2021 Aug 7. pii: S0264-410X(21)00907.
PMID: 34373117